• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TEC 家族激酶及其抑制剂在斑秃治疗中的研究进展。

A review of TEC family kinases and their inhibitors in the treatment of alopecia areata.

机构信息

School of Clinical Medicine, Peking University Health Science Center, Beijing, 100191, China.

Department of Dermatology and Venereology, Hair Medical Research Center, Beijing Jishuitan Hospital, Capital Medical University, No. 31 of Xinjiekou East Street, Xicheng District, Beijing, 100035, China.

出版信息

Arch Dermatol Res. 2024 Jul 30;316(8):496. doi: 10.1007/s00403-024-03229-0.

DOI:10.1007/s00403-024-03229-0
PMID:39080140
Abstract

The TEC (tyrosine kinase expressed in hepatocellular carcinoma) family kinases, an important class of protein kinases, play key roles in cell signaling and immune regulation. In this review, the association between the pathogenesis of alopecia areata and the structure and regulatory mechanisms of TEC family kinases in normal physiological processes, is explored. Furthermore, the potential clinical applications of TEC kinases and their inhibitors are highlighted by summarizing current insights into their mechanisms of action, clinical applications, and recent advancements in TEC kinase inhibitor research.

摘要

TEC(肝癌细胞中表达的酪氨酸激酶)家族激酶是一类重要的蛋白激酶,在细胞信号转导和免疫调节中发挥关键作用。本综述探讨了斑秃发病机制与 TEC 家族激酶在正常生理过程中的结构和调节机制之间的关联。此外,通过总结 TEC 激酶及其抑制剂的作用机制、临床应用以及最近在 TEC 激酶抑制剂研究方面的进展,强调了 TEC 激酶及其抑制剂的潜在临床应用。

相似文献

1
A review of TEC family kinases and their inhibitors in the treatment of alopecia areata.TEC 家族激酶及其抑制剂在斑秃治疗中的研究进展。
Arch Dermatol Res. 2024 Jul 30;316(8):496. doi: 10.1007/s00403-024-03229-0.
2
Tec kinases in T cell and mast cell signaling.T细胞和肥大细胞信号传导中的 Tec激酶
Adv Immunol. 2007;93:145-84. doi: 10.1016/S0065-2776(06)93004-1.
3
The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.辅助因子 Nef 通过Src 同源 3 结构域依赖的方式将 HIV-1 与 Tec/Btk 激酶联系起来。
J Biol Chem. 2014 May 30;289(22):15718-28. doi: 10.1074/jbc.M114.572099. Epub 2014 Apr 10.
4
Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk.非典型tec家族酪氨酸激酶Bmx和Txk对Btk信号的重建。
J Biol Chem. 1999 May 7;274(19):13577-85. doi: 10.1074/jbc.274.19.13577.
5
Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis.布鲁顿酪氨酸激酶和Tec激酶在Fcγ受体诱导的信号传导和吞噬作用中的双重功能。
J Immunol. 2008 Jul 1;181(1):288-98. doi: 10.4049/jimmunol.181.1.288.
6
Inhibiting Janus kinases to treat alopecia areata.抑制 Janus 激酶治疗斑秃。
Nat Med. 2014 Sep;20(9):989-90. doi: 10.1038/nm.3685.
7
The role of Tec family kinases in the regulation of T-helper-cell differentiation.Tec 家族激酶在调节辅助性 T 细胞分化中的作用。
Int Rev Immunol. 2012 Apr;31(2):133-54. doi: 10.3109/08830185.2012.664798.
8
A FLIPR-based assay to assess potency and selectivity of inhibitors of the TEC family kinases Btk and Itk.一种基于荧光成像板读数器的检测方法,用于评估 Tec 家族激酶 Btk 和 Itk 抑制剂的效力和选择性。
Assay Drug Dev Technol. 2007 Dec;5(6):751-8. doi: 10.1089/adt.2007.9982.
9
Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases.人源布鲁顿酪氨酸激酶在活性和非活性构象下的结构揭示了 TEC 家族激酶的激活机制。
Protein Sci. 2010 Mar;19(3):429-39. doi: 10.1002/pro.321.
10
Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.Tec、Itk和Btk在淋巴细胞中的表达与功能:Tec独特作用的证据
Mol Cell Biol. 2004 Mar;24(6):2455-66. doi: 10.1128/MCB.24.6.2455-2466.2004.

本文引用的文献

1
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia.真实世界中,开始使用伊布替尼治疗后,医疗保险受益人群中慢性淋巴细胞白血病的不良反应发生率分析。
Cancer Med. 2024 Jan;13(2):e6953. doi: 10.1002/cam4.6953.
2
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.ALLEGRO 临床试验项目中口服 JAK3/TEC 家族激酶抑制剂利特昔替尼治疗斑秃的综合安全性分析。
Am J Clin Dermatol. 2024 Mar;25(2):299-314. doi: 10.1007/s40257-024-00846-3. Epub 2024 Jan 23.
3
Inhibition of T-cell activity in alopecia areata: recent developments and new directions.
斑秃中 T 细胞活性的抑制:最新进展和新方向。
Front Immunol. 2023 Nov 6;14:1243556. doi: 10.3389/fimmu.2023.1243556. eCollection 2023.
4
Recent advances in genomics and therapeutics in mantle cell lymphoma.套细胞淋巴瘤的基因组学和治疗学的最新进展。
Cancer Treat Rev. 2024 Jan;122:102651. doi: 10.1016/j.ctrv.2023.102651. Epub 2023 Nov 4.
5
An Updated Review on Current Treatment of Alopecia Areata and Newer Therapeutic Options.斑秃当前治疗方法及新型治疗选择的最新综述
Int J Trichology. 2023 Jan-Feb;15(1):3-12. doi: 10.4103/ijt.ijt_28_21. Epub 2023 Apr 19.
6
Protein kinases: drug targets for immunological disorders.蛋白激酶:免疫性疾病的药物靶点。
Nat Rev Immunol. 2023 Dec;23(12):787-806. doi: 10.1038/s41577-023-00877-7. Epub 2023 May 15.
7
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.利特昔替尼治疗成人和青少年斑秃的疗效和安全性:一项随机、双盲、多中心、2b-3 期临床试验。
Lancet. 2023 May 6;401(10387):1518-1529. doi: 10.1016/S0140-6736(23)00222-2. Epub 2023 Apr 14.
8
Fenebrutinib and BTK inhibition: Unveiling a new target for the treatment of chronic spontaneous urticaria.非奈布替尼与布鲁顿酪氨酸激酶抑制作用:揭示慢性自发性荨麻疹治疗的新靶点
Allergy. 2023 Feb;78(2):603-605. doi: 10.1111/all.15592. Epub 2022 Dec 7.
9
Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata.JAK1/3 抑制诱导斑秃 T 细胞耗竭的治疗作用。
Front Immunol. 2022 Sep 20;13:955038. doi: 10.3389/fimmu.2022.955038. eCollection 2022.
10
Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical.伊布替尼相关性心脏毒性:从药物到临床。
Drug Des Devel Ther. 2022 Sep 20;16:3225-3239. doi: 10.2147/DDDT.S377697. eCollection 2022.